Canadian Oxycontin and OxyNEO Class Action Settlement

A class action lawsuit against the manufacturers of certain opioid medications settled recently. Anyone who was prescribed, ingested and then developed an addiction to OxyContin and/or OxyNEO tablets in Canada between January 1, 1996, and February 28, 2017, is eligible to claim compensation under the settlement. Estates of deceased people in Canada who are also eligible to file claims, as are spouses, children, and certain other family members. If you first consumed OxyContin and/or OxyNEO without a prescription, you cannot apply for compensation. Class members have until February 27th, 2024, to file a claim.

On June 8, 2007, the law firms of Rochon Genova LLP and Siskinds LLP filed a class action against the drug manufacturers, Purdue Pharma, and various affiliated entities. HALCO is not involved in this class action.

The Canadian OxyContin Class Action Settlement has received the required court approvals and class members can file claims to get compensation.

For more information, please read the Notice of Settlement Approval. Class members’ rights under the Settlement are explained in the notice.

For more information about the Settlement, including how to file a claim, visit the Canadian OxyContin Class Action Settlement website at: http://www.oxycontinclassactionsettlement.ca/ or contact the claims administrator at 1-888-663-7185 or oxycontin@ricepoint.com.

If you are living with HIV and have questions about other legal issues, please contact HALCO.

This entry was posted in News. Bookmark the permalink.